Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.
about
The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes.A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.Practical approaches to the use of lenalidomide in multiple myeloma: a canadian consensus.Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy.Lenalidomide in multiple myeloma: current experimental and clinical data.HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideCurrent multiple myeloma treatment strategies with novel agents: a European perspectiveCost-effectiveness of lenalidomide in multiple myeloma.Continuous treatment in multiple myeloma - ready for prime time?Emerging pathways as individualized therapeutic target of multiple myeloma.Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma.
P2860
Q33398044-D2AF617B-62A4-45AF-BD0E-4A403BE0C900Q33399844-5A4ED970-B331-4365-9A70-02C32D9320E2Q33404007-33001A1E-4855-4307-A7DF-E0B018D4708CQ33973877-1C54B84C-B968-4E46-81E0-BFDA098D2A7EQ34074803-6341DE49-6177-4C7C-8492-A5E9946D1C93Q36544516-8DEB400D-4B02-45F9-B923-A8CA99FCFC08Q37677935-F791E7DC-DFDB-4C85-BAFD-1944CDFC516BQ37764870-7A6B0FB1-D595-4EFE-8670-61A9C6538B7EQ37936111-43A2277F-7BBE-4767-B182-AB1F6EF2E424Q38112176-00763C76-A82E-41B9-9383-360D18B2181BQ44512399-AAC00C5F-C874-4154-8D62-2DFF6303DAAD
P2860
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Melphalan, prednisone, and len ...... nia and time-to-event results.
@ast
Melphalan, prednisone, and len ...... nia and time-to-event results.
@en
type
label
Melphalan, prednisone, and len ...... nia and time-to-event results.
@ast
Melphalan, prednisone, and len ...... nia and time-to-event results.
@en
prefLabel
Melphalan, prednisone, and len ...... nia and time-to-event results.
@ast
Melphalan, prednisone, and len ...... nia and time-to-event results.
@en
P2093
P50
P356
P1476
Melphalan, prednisone, and len ...... nia and time-to-event results.
@en
P2093
Andrea Nozza
Annalisa Luraschi
Antonietta Falcone
Fortunato Morabito
Francesca Gay
Giulia Benevolo
Jerome B Zeldis
Letizia Canepa
Maria Teresa Petrucci
Mario Boccadoro
P304
P356
10.3816/CLM.2009.N.035
P577
2009-04-01T00:00:00Z